PCBL Chemical Limited Seeks Debenture Holders' Approval for Financial Covenant Deferral

2 min read     Updated on 09 Mar 2026, 08:44 PM
scanx
Reviewed by
Shriram SScanX News Team
Overview

PCBL Chemical Limited has formally communicated to stock exchanges about its Fund Raising Committee's approval for amendments to defer financial covenant testing for FY2025-26. The company seeks debenture holders' approval through a meeting scheduled for March 13, 2026 on shorter notice, with Catalyst Trusteeship Limited coordinating the process for the ₹700 crores non-convertible debentures.

34614785

*this image is generated using AI for illustrative purposes only.

PCBL Chemical Limited has announced that its Fund Raising Committee approved amendments to the debenture trust deed dated January 20, 2024, seeking to defer the testing of financial covenants for the financial year 2025-2026. The decision was made at a committee meeting held on March 9, 2026, as communicated to stock exchanges under SEBI Listing Regulations.

Official Communication and Documentation

The company has issued formal intimation to NSE and BSE regarding the Fund Raising Committee meeting outcome. Company Secretary and Chief Legal Officer K. Mukherjee digitally signed the communication on March 9, 2026, referencing the company's earlier letter dated March 4, 2026. The communication was made pursuant to Regulations 30 and 51 of the SEBI Listing Obligations and Disclosure Requirements Regulations, 2015.

Communication Details: Information
Date: March 9, 2026
Signatory: K. Mukherjee, Company Secretary
Reference: Letter dated March 4, 2026
Regulations: SEBI Regulations 30 and 51

Debenture Holders Meeting Details

The company has requested Catalyst Trusteeship Limited, acting as the debenture trustee, to convene a meeting of debenture holders on March 13, 2026, on shorter notice. The meeting will address amendments to the debenture trust deed for non-convertible debentures aggregating up to ₹700 crores (ISIN: INE602A07020).

Meeting Parameter: Details
Date: March 13, 2026
Notice Period: Shorter notice
Mode: Virtual meeting via Microsoft Teams
Debenture Value: ₹700 crores
ISIN: INE602A07020

Proposed Amendments and Approval Requirements

The meeting agenda includes two key items requiring different levels of approval from debenture holders. Agenda Item 1 seeks to defer the testing of the financial covenant on "Consolidated Gross Debt / EBITDA" for the financial year 2025-2026, requiring Special Approval representing more than 75% of outstanding debentures. Agenda Item 2 involves ratification and confirmation of procedural matters, including the conduct of the meeting through Microsoft Teams, requiring Simple Approval representing more than 50% of outstanding debentures.

Approval Type: Threshold Agenda Item
Special Approval: >75% Financial covenant deferral
Simple Approval: >50% Procedural matters

Trustee Communication to Debenture Holders

Catalyst Trusteeship Limited has begun reaching out to debenture holders based on the latest beneficial position received from the issuer company dated February 27, 2026. The trustee sent communications on March 9, 2026, seeking approval from debenture holders for calling the meeting on shorter notice to amend the debenture trust deed.

Business Rationale and Regulatory Compliance

According to the company's explanatory statement, the proposed deferral of financial covenant testing is intended to support and implement planned growth and business expansion initiatives. The existing debenture trust deed contains financial covenants on "Consolidated Gross Debt / EBITDA" as outlined in Schedule V of the agreement. The original debenture trust deed was executed on January 20, 2024, and has been previously amended through a first amendment deed dated January 27, 2024, and a second amendment deed dated March 20, 2025.

Historical Stock Returns for PCBL Chemical

1 Day5 Days1 Month6 Months1 Year5 Years
-0.42%-4.90%-14.75%-30.61%-28.39%+159.79%

PCBL Chemical Limited receives reaffirmed credit ratings from ICRA for Rs. 2,400.00 crores worth instruments

1 min read     Updated on 12 Feb 2026, 07:28 PM
scanx
Reviewed by
Jubin VScanX News Team
Overview

ICRA Limited reaffirmed credit ratings for PCBL Chemical Limited's financial instruments worth Rs. 2,400.00 crores on 12th February, 2026. The rating agency maintained [ICRA]AA(Negative) ratings for long-term facilities including NCDs (Rs. 700.00 crores), term loans (Rs. 583.10 crores), working capital term loan (Rs. 480.00 crores), and unallocated facility (Rs. 136.90 crores), while reaffirming [ICRA]A1+ rating for commercial paper (Rs. 500.00 crores). The company has duly informed stock exchanges about these rating reaffirmations under regulatory compliance requirements.

32450308

*this image is generated using AI for illustrative purposes only.

PCBL Chemical Limited has received reaffirmed credit ratings from ICRA Limited for various financial instruments totaling Rs. 2,400.00 crores. The rating agency communicated its decision on 12th February, 2026, maintaining existing ratings across multiple credit facilities and instruments.

Credit Rating Details

ICRA Limited has reaffirmed ratings for five different financial instruments of the company. The rating actions cover both long-term and short-term credit facilities across various categories.

Instrument Amount (Rs. in crores) Rating Rating Action
Non-Convertible Debentures (NCD) 700.00 [ICRA]AA(Negative) Reaffirmed
Commercial Paper 500.00 [ICRA]A1+ Reaffirmed
Long Term-Fund Based-Working Capital Term Loan 480.00 [ICRA] AA (Negative) Reaffirmed
Long Term-Fund Based-Term Loan 583.10 [ICRA] AA (Negative) Reaffirmed
Long Term-Unallocated 136.90 [ICRA] AA (Negative) Reaffirmed

Rating Categories

The reaffirmed ratings include both long-term and short-term categories. Long-term instruments totaling Rs. 1,900.00 crores received [ICRA]AA(Negative) ratings, while the Commercial Paper facility of Rs. 500.00 crores maintained its [ICRA]A1+ rating.

The largest single facility is the Non-Convertible Debentures program worth Rs. 700.00 crores, followed by the Term Loan facility of Rs. 583.10 crores. The Working Capital Term Loan stands at Rs. 480.00 crores, with an additional Long Term-Unallocated facility of Rs. 136.90 crores.

Regulatory Compliance

PCBL Chemical Limited has informed both National Stock Exchange of India Limited and BSE Limited about the credit rating reaffirmations as per regulatory requirements. The company secretary and chief legal officer K. Mukherjee signed the disclosure document on 12th February, 2026.

The company, formerly known as PCBL Limited, maintains its registered office at 31 Netaji Subhas Road, Kolkata, and corporate office at RPSG House in Kolkata. The rating reaffirmations provide continuity in the company's credit profile across its diverse funding requirements.

Historical Stock Returns for PCBL Chemical

1 Day5 Days1 Month6 Months1 Year5 Years
-0.42%-4.90%-14.75%-30.61%-28.39%+159.79%

More News on PCBL Chemical

1 Year Returns:-28.39%